MAINZ BIOMED N V
(NASDAQ: MYNZ)
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
0.763
-0.117
(-13.30%)
Range
- - -
(-%)
Open
-
Previous Close
0.880
Bid Price
4.550
Bid Volume
14
Ask Price
5.220
Ask Volume
9
Volume
139,419
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis